implementation, blood management, total hip arthroplasty, total knee arthroplasty, behavior change implementatie, bloed management, totale heup arthroplastiek, totale knie arthroplastiek, gedragsverandering
Conditions
Interventions
- Interactive education aimed at orthopedic surgeons and anesthesiologists
- Feedback in an educational outreach visit aimed at orthopedic surgeons and anesthesiologists
- Dissemination and reports
Sponsors
Leiden University Medical Center
P.O. Box 9600, 2300 RC Leiden, the Netherlands
Eligibility
Inclusion criteria
Inclusion criteria: - Hospitals using EPO and/or blood salvage in patients undergoing primary elective THA or TKA on a regular basis (more frequently than in exceptional cases) - Hospitals performing at least 50 THA and/or TKA on average per 5 months.
Exclusion criteria
Exclusion criteria: - Hospitals considering to abandon the use of EPO or blood salvage on their own initiative - Hospitals participating in trials that interfere with the use or the discontinuation of EPO or blood salvage - Hospitals employing the same group of orthopaedic surgeons or anaesthesiologists as a previous included hospital.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the % of patients undergoing primary elective total hip or knee arthroplasty in which EPO or blood salvage is applied. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study parameters are the patient outcomes of the surgery including post-operative hemoglobin (Hb) level, length of hospital stay and number of allogeneic transfusions. Also possible complications will be registered: reactions on EPO use, transfusion reactions due to the use of blood salvage, transfusion reactions due to allogeneic transfusions, other (serious) adverse events. | — |
Contacts
Public ContactV.M.A. Voorn
Department of Medical Decision Making, Postzone J10-s, room J10-88 P.O. Box 9600,
Outcome results
None listed